Literature DB >> 1082888

Suppressor thymus-derived lymphocytes in fungal infection.

J D Stobo, S Paul, R E Van Scoy, P E Hermans.   

Abstract

Thymus-derived lymphocyte (T-cell) function, as determined in vivo by cutaneous reactivity to several antigens and in vitro by responsiveness to mitogens and antigens, was assessed in 14 patients infected with a variety of fungal organisms. While all patients manifested a normal frequency of peripheral blood T cells, only seven patients reacted to at least one of the antigens used for cutaneous testing and demonstrated normal in vitro T proliferative responses. Three patients exhibited cutaneous anergy but normal in vitro T-cell reactivity while four patients demonstrated persistent anergy and marked in vitro T-cell hyporeactivity which was independent of activity of infection, concurrent medication, or any associated disorders. The marked diminution of in vitro T-cell reactivity noted for these later four patients was not due to a deletion of antigen- or mitogen-reactive cells. Thus, patients' cells which had been initially cultured for 7 days without any mitogenic or antigenic stimulus and which were subsequently washed and recultured with phytohemagglutinin, concanavalin A, or histoplasmin demonstrated a marked increase in their responsiveness. Moreover, this reactivity noted for recultured cells could be suppressed by a nonphagocytic, nonadherent, nonimmunoglobulin-bearing, sheep red blood cell rosette-forming population of cells isolated from the fresh peripheral blood mononuclear cells of the same patient. While these "regulator" T cells were capable of suppressing T-proliferative responses to antigens and mitogens, they did not diminish pokeweed mitogen-induced immunoglobulin synthesis by normal bone marrow-derived lymphocytes. Patients in whom suppressor "T" cells were found were at risk for relapsing, disseminated fungal infection.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1082888      PMCID: PMC436656          DOI: 10.1172/JCI108283

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Demonstration of suppressor T cells in a population of 'educated' T cells.

Authors:  M J Taussig
Journal:  Nature       Date:  1974-03-15       Impact factor: 49.962

2.  Variation in lymphocyte reactivity to histoplasmin during the course of chronic pulmonary histoplasmosis.

Authors:  R H Alford; R A Goodwin
Journal:  Am Rev Respir Dis       Date:  1973-07

3.  Disseminated cryptococcosis in man: decreased lymphocyte transformation in response to Cryptococcus neoformans.

Authors:  R D Diamond; J E Bennett
Journal:  J Infect Dis       Date:  1973-06       Impact factor: 5.226

4.  Cell-mediated immunity in Cryptococcosis.

Authors:  J R Graybill; R H Alford
Journal:  Cell Immunol       Date:  1974-10       Impact factor: 4.868

5.  Inhibition of mixed leukocyte culture responses by serum and gamma-globulin fractions from certain patients with connective tissue disorders.

Authors:  R C Williams; R B Lies; R P Messner
Journal:  Arthritis Rheum       Date:  1973 Sep-Oct

6.  Role of the thymus in tolerance. 8. Relative effectiveness of nonaggregated and heat-aggregated bovine gamma globulin, injected directly into lymphoid organs of normal rats, in suppressing immune responsiveness.

Authors:  A Horiuchi; B H Waksman
Journal:  J Immunol       Date:  1968-12       Impact factor: 5.422

7.  Immune abnormalities associated with chronic mucocutaneous candidiasis.

Authors:  H Valdimarsson; J M Higgs; R S Wells; M Yamamura; J R Hobbs; P J Holt
Journal:  Cell Immunol       Date:  1973-03       Impact factor: 4.868

8.  Immunotherapy of coccidioidomycosis.

Authors:  A Catanzaro; L Spitler; K M Moser
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

9.  Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody response.

Authors:  R A Murgita; T B Tomasi
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

10.  Functional heterogeneity of murine lymphoid cells. V. Lymphocytes lacking detectable surface theta or immunoglobulin determinants.

Authors:  J D Stobo; A S Rosenthal; W E Paul
Journal:  J Exp Med       Date:  1973-07-01       Impact factor: 14.307

View more
  81 in total

1.  Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization.

Authors:  C Fiocchi; J R Battisto; R G Farmer
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

2.  Inhibition of humoral and cell-mediated immune responses in man by distinct suppressor cell systems.

Authors:  P I Lobo; C E Spencer
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

3.  Lymphocyte suppressor activity in atopic eczema.

Authors:  B E Ogden; G G Krueger; H R Hill
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

4.  Behaviour of human immunoregulatory cells in culture. I. Variables requiring consideration for clinical studies.

Authors:  J M Dwyer; C Johnson; M Desaules
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

5.  'Long-distance' lymphocyte study. The effects of transporting blood in lymphocyte blastogenic responses.

Authors:  E A Ottesen; R W Poindexter; R A Hiatt
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

6.  In vitro studies of suppressor cell function in human peripheral blood mononuclear cells.

Authors:  C Feighery; C A Whelan; D G Weir; J F Greally
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

7.  Immunoregulatory responses in experimental disseminated histoplasmosis: lymphoid organ histopathology and serological studies.

Authors:  R P Artz; W E Bullock
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

Review 8.  Cell-mediated immunity during syphilis.

Authors:  C S Pavis; J D Folds; J B Baseman
Journal:  Br J Vener Dis       Date:  1978-06

9.  Modification by suppressor cells and serum factors of the cell-mediated immune response in experimental pyelonephritis.

Authors:  T Miller; L Scott; E Stewart; D North
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

10.  Inhibition of polyclonal B-cell activation by suppressor monocytes in patients with sarcoidosis.

Authors:  P Katz; A S Fauci
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.